As a world leader in pharmaceutical services, Almac delivers early formulation development work programs for DRF/PK/tox studies. Designed to maximise solubility and bioavailability without compromising on chemical stability, the studies accelerate drug development to the clinic and minimize risk in any downstream activities. Almac offer bespoke work packages specifically tailored to the physiochemical properties of the API (BCS class II, III, or IV) for solubility or permeability enhancement.
Read the full article below to find out more.View Resource
Almac API, Chemical Development, Analytical & Solid State Services
Almac Sciences provides integrated services from development to commercial scale of advanced intermediates and Active Pharmaceutical Ingredients (API).
We provide a range of services for small molecules (including highly potent) and peptides. We have a proven track record of saving time and cost through the integration of our services and application of innovative biocatalysis and technology solutions.
We offer a full suite of analytical testing for a range of different product types including small molecules, peptides, biologics, conjugates, potent and controlled substances.
Our vast pool of scientific knowledge can help to overcome the analytical challenges that typically arise during drug development.